While pharma has historically shied away from engaging too closely with patients, the risk now lies in failing to engage patients in R&D. Patient involvement leads to higher-quality evidence and more clinically significant innovations. We will help you develop the practices and partnerships needed to establish long-term, mutually beneficial patient engagement programs that align stakeholders across the drug development cycle. We will do all the heavy lifting:
With over 30 years of biopharmaceutical industry experience, we have played a role in every step of the drug development process.
- Rare disease
- Eye care
- Intellectual and developmental disabilities
- Patient advocacy and relations
- Research and development
- Medical affairs
- Drug safety
- Government affairs
"Cheryl helped Upstage Lung Cancer expand our development efforts to better utilize technology, consider new sources of partnerships and funding, and establish collaborations with larger organizations. She is well known in the pharmaceutical and patient advocacy communities, which allows her to create and extend relationships that benefit both parties. Cheryl is without a doubt one of the most effective, competent, and easy to work with consultants I know."
- Hildy Grossman, Ph.D., President and Founder, Upstage Lung Cancer
Copyright © 2021 Red Thred Solutions - All rights reserved.